Apex BioTechnology Corp. · Class II · Cleared Nov 4, 2022
| K-number | K220421 |
| Device name | BGM039 Blood Glucose Monitoring System, BGM039 Link Blood Glucose Monitoring System |
| Applicant | Apex BioTechnology Corp. |
| Product code | NBW |
| Device class | Class II |
| Decision date | Nov 4, 2022 |
| Decision | Substantially Equivalent |
| Regulation | 862.1345 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov